Related Experiment Video
Updated: May 11, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Electrocardiographic predictors of sudden cardiac death in patients with left ventricular hypertrophy
Ragesh Panikkath1, Kyndaron Reinier, Audrey Uy-Evanado
1Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.
Insights
Prolonged QTc intervals are linked to sudden cardiac death (SCD) in patients with left ventricular hypertrophy (LVH). This finding may improve risk stratification for SCD in LVH patients.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Diagnostics
Background:
- Left ventricular hypertrophy (LVH) is a known risk factor for sudden cardiac death (SCD).
- Current risk stratification methods for SCD in LVH require enhancement.
- Electrocardiographic (EKG) intervals are being investigated as potential markers for SCD risk.
Purpose of the Study:
- To evaluate electrocardiographic intervals as potential markers of SCD risk in individuals with LVH.
- To determine if specific EKG intervals can predict SCD in the LVH population.
Main Methods:
- Retrospective analysis of consecutive SCD cases with LVH from the Oregon Sudden Unexpected Death study.
- Comparison of EKG intervals (QTc, QRS, JT) and clinical data between SCD cases and matched controls.
- LVH assessment using the modified American Society of Echocardiography equation; statistical analysis via t-tests, chi-square, and logistic regression.
Main Results:
- No significant difference in LV mass index between cases and controls.
- Significantly higher mean QTc (470.6 ms vs 440.7 ms) and QRS duration (113.6 ms vs 104.9 ms) in SCD cases compared to controls.
- Prolonged QTc interval was independently associated with SCD in logistic regression (OR 1.72).
Conclusions:
- Prolonged QTc interval is independently associated with SCD in patients with LVH.
- QTc interval warrants further investigation as a predictive marker for SCD in LVH.
- Improved risk stratification for SCD in LVH may be achieved through EKG interval analysis.
Background:
Left ventricular hypertrophy (LVH) has been associated with increased risk of sudden cardiac death (SCD), and improvements in risk stratification methodology are warranted.
Methods:
We evaluated electrocardiographic intervals as potential markers of SCD risk in LVH. Corrected QT, QRS, and JT intervals were evaluated in consecutive cases with SCD and LVH from the ongoing Oregon Sudden Unexpected Death study who underwent a 12-lead electrocardiogram (EKG) and echocardiogram prior to and unrelated to the SCD event. Comparisons of age, gender, body mass index, LV ejection fraction, and EKG intervals together with clinical conditions (hypertension and diabetes) were conducted with geographically matched controls that had coronary artery disease but no history of ventricular arrhythmias or cardiac arrest. LVH was determined using the modified American Society of Echocardiography equation for LV mass. Independent samples t-test, Pearson's chi-square test, and multiple logistic regression were used for statistical comparisons.
Results:
Of the 109 cases and 49 controls who met study criteria, age, gender, and comorbidities were similar among cases and controls. The mean LV mass index was not significantly different in cases compared to controls. However mean QTc (470.6 ± 53.6 ms vs 440.7 ± 38.7 ms; P < 0.0001) and QRS duration (113.6 ± 30.0 ms vs 104.9 ± 18.7 ms; P = 0.03) were significantly higher in cases than controls. In logistic regression analysis, prolonged QTc was the only EKG interval significantly associated with SCD (OR 1.72 [1.23-2.40]).
Conclusion:
Prolonged QTc was independently associated with SCD among subjects with LVH and merits further evaluation as a predictor of SCD in LVH.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies